Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Licensing opportunity from NIH: novel antitumor macrocyclic lactones

July 9, 2001

Steroid sulfatase inhibitors in development by Novartis for cancer, etc.

July 6, 2001

Enzyme-inducing sulfenate and thiosulfinate esters described by U.S. university

July 6, 2001

WHI-P154 claimed for sensitizing cancer cells to radiation

July 6, 2001

Several series of antineoplastic agents presented by ADIR in patents

July 6, 2001

FDA grants approval for Debiopharm's Trelstar LA for use in advanced prostate cancer

July 6, 2001

Wyeth-Ayerst and Taxolog to develop novel taxanes

July 6, 2001

Peregrine's TNT treatment shows positive results in phase I/II trial

July 5, 2001

Bradykinin B2 antagonists with anticancer activity

July 5, 2001

AEterna's Neovastat demonstrates safety and dose-related activity in prostate cancer trial

July 5, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...